全文获取类型
收费全文 | 3851篇 |
免费 | 387篇 |
国内免费 | 269篇 |
出版年
2024年 | 6篇 |
2023年 | 29篇 |
2022年 | 64篇 |
2021年 | 149篇 |
2020年 | 100篇 |
2019年 | 149篇 |
2018年 | 144篇 |
2017年 | 120篇 |
2016年 | 166篇 |
2015年 | 264篇 |
2014年 | 281篇 |
2013年 | 296篇 |
2012年 | 365篇 |
2011年 | 325篇 |
2010年 | 212篇 |
2009年 | 191篇 |
2008年 | 232篇 |
2007年 | 201篇 |
2006年 | 162篇 |
2005年 | 140篇 |
2004年 | 139篇 |
2003年 | 125篇 |
2002年 | 118篇 |
2001年 | 69篇 |
2000年 | 52篇 |
1999年 | 55篇 |
1998年 | 27篇 |
1997年 | 21篇 |
1996年 | 26篇 |
1995年 | 16篇 |
1994年 | 21篇 |
1993年 | 24篇 |
1992年 | 22篇 |
1991年 | 14篇 |
1990年 | 18篇 |
1989年 | 13篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 16篇 |
1985年 | 6篇 |
1984年 | 12篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 6篇 |
1976年 | 8篇 |
1975年 | 11篇 |
1974年 | 9篇 |
排序方式: 共有4507条查询结果,搜索用时 15 毫秒
141.
Chi Yuet X’avia Chan Marina A. Gritsenko Richard D. Smith 《Expert review of proteomics》2016,13(4):421-433
Protein phosphorylation is a fundamental regulatory mechanism in many cellular processes and aberrant perturbation of phosphorylation has been implicated in various human diseases. Kinases and their cognate inhibitors have been considered as hotspots for drug development. Therefore, the emerging tools, which enable a system-wide quantitative profiling of phosphoproteome, would offer a powerful impetus in unveiling novel signaling pathways, drug targets and/or biomarkers for diseases of interest. This review highlights recent advances in phosphoproteomics, the current state of the art of the technologies and the challenges and future perspectives of this research area. Finally, some exemplary applications of phosphoproteomics in diabetes research are underscored. 相似文献
142.
High glucose concentration induces endothelial cell proliferation by regulating cyclin‐D2‐related miR‐98
下载免费PDF全文
![点击此处可从《Journal of cellular and molecular medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Xin‐Xin Li Yue‐Mei Liu You‐Jie Li Ning Xie Yun‐Fei Yan Yong‐Liang Chi Ling Zhou Shu‐Yang Xie Ping‐Yu Wang 《Journal of cellular and molecular medicine》2016,20(6):1159-1169
Cyclin D2 is involved in the pathology of vascular complications of type 2 diabetes mellitus (T2DM). This study investigated the role of cyclin‐D2‐regulated miRNAs in endothelial cell proliferation of T2DM. Results showed that higher glucose concentration (4.5 g/l) significantly promoted the proliferation of rat aortic endothelial cells (RAOECs), and significantly increased the expression of cyclin D2 and phosphorylation of retinoblastoma 1 (p‐RB1) in RAOECs compared with those under low glucose concentration. The cyclin D2‐3′ untranslated region is targeted by miR‐98, as demonstrated by miRNA analysis software. Western blot also confirmed that cyclin D2 and p‐RB1 expression was regulated by miR‐98. The results indicated that miR‐98 treatment can induce RAOEC apoptosis. The suppression of RAOEC growth by miR‐98 might be related to regulation of Bcl‐2, Bax and Caspase 9 expression. Furthermore, the expression levels of miR‐98 decreased in 4.5 g/l glucose‐treated cells compared with those treated by low glucose concentration. Similarly, the expression of miR‐98 significantly decreased in aortas of established streptozotocin (STZ)‐induced diabetic rat model compared with that in control rats; but cyclin D2 and p‐RB1 levels remarkably increased in aortas of STZ‐induced diabetic rats compared with those in healthy control rats. In conclusion, this study demonstrated that high glucose concentration induces cyclin D2 up‐regulation and miR‐98 down‐regulation in the RAOECs. By regulating cyclin D2, miR‐98 can inhibit human endothelial cell growth, thereby providing novel therapeutic targets for vascular complication of T2DM. 相似文献
143.
144.
145.
146.
Chunhua Xu Yuchao Wang Qi Yuan Wei Wang Chuanzhen Chi Qian Zhang Xiuwei Zhang 《Journal of cellular and molecular medicine》2019,23(3):2077-2082
Pleiotrophin (PTN) is involved in tumour progression, angiogenesis and metastasis. The purpose of this study was to investigate the expression level of PTN in the serum of patients with small cell lung cancer (SCLC) and to explore the clinical significance of PTN. Serum samples from 128 patients with SCLC, 120 healthy volunteers (HV) and 60 patients with benign lung disease (BLD) were collected. The levels of serum PTN were determined with ELISA and its correlation with the clinical data was examined. The serum PTN levels in SCLC patients were significantly higher than that in BLD patients (P < 0.05) or HV (P < 0.05). With a cutoff value of 258.18 ng/mL, the sensitivity and specificity of PTN to SCLC patients and BLD patients, SCLC patients and HV were 79.2% and 91.7%, 86.7% and 95.8% respectively. An area under the curve for all stages of SCLC resulting from PTN, which was significantly better than the other tumour markers tested including progastrin‐releasing peptide and neuron‐specific enolase. High serum PTN levels appear to correlate with poor survival in patients with SCLC. These results suggest that PTN levels in the serum could be a new effective biomarker for the diagnosis and prognosis of SCLC. 相似文献
147.
Da Sun Jia Chen Wei Wu Ju Tang Li Luo Kun Zhang Libo Jin Sue Lin Yitian Gao Xiaoqing Yan Chi Zhang 《Journal of cellular and molecular medicine》2019,23(4):2863-2871
Obesity is associated with significant microvascular complications including renal injuries and may induce end‐stage renal disease. Emerging studies have demonstrated microRNAs (miRNAs) are potential mediators in the pathophysiological process of nephropathy. The present study aimed to investigate the role of miR‐802 in obesity‐related nephropathy and potential molecular mechanisms. Through utilizing obese mouse model and human subjects, we explored the therapeutic benefits and clinical application of miR‐802 in protecting against nephropathy. Renal miR‐802 level was positively correlated with functional parameters, including blood urea nitrogen and creatinine in obese mice. Specific silencing of renal miR‐802 improved high fat diet (HFD)‐induced renal dysfunction, structural disorders and fibrosis. The up‐regulated inflammatory response and infiltrated macrophages were also significantly decreased in miR‐802 inhibitor‐treated obese mice. Mechanistically, miR‐802 directly bond to 3?‐UTR of NF‐κB‐repressing factor (NRF) and suppressed its expression. In clinical study, the circulating miR‐802 level was significantly increased in obese subjects, and positively correlated with plasma creatinine level but negatively correlated with creatinine clearance. Taken together, our findings provided evidence that miR‐802/NRF signalling was an important pathway in mediating obesity‐related nephropathy. It is a possible useful clinical approach of treating miR‐802 inhibitor to combat nephropathy. 相似文献
148.
Site-directed RNA editing (SDRE) is invaluable to basic research and clinical applications and has emerged as a new frontier in genome editing. The past few years have witnessed a surge of interest in SDRE, with SDRE tools emerging at a breathtaking pace. However, off-target effects of SDRE remain a tough problem, which constitutes a major hurdle to their clinical applications. Here we discuss the diverse strategies for combating off-target editing, drawing lessons from the published studies as well as our ongoing research. Overall, SDRE is still at its infancy, with significant challenges and exciting opportunities ahead. 相似文献
149.